UPDATE: Piper Jaffray Raises Price Target on Thoratec to $33

Loading...
Loading...
According to Piper Jaffray, Thoratec
THOR
price target is raised to $33. Piper Jaffray said that it is incrementally more positive on Neutral-rated THOR after attending the HFSA convention in Boston. “We are increasing our price target to $33/share to reflect current Medtech multiples and our updated estimates.” Thoratec closed yesterday at $30.43.
Posted In: Analyst ColorPrice TargetAnalyst RatingsPiper Jaffray
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...